Literature DB >> 4357610

Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.

L Blonde, R E Wehmann, A L Steiner.   

Abstract

Previously, in an attempt to understand the mechanisms involved in the regulation of plasma cyclic nucleotides, we measured concentrations of adenosine 3',5'-monophosphate (cAMP) and guanosine 3',5'-monophosphate (cGMP) in plasma from selected blood vessels of anesthetized dogs. The observation that the renal venous plasma concentrations of both cyclic nucleotides were less than arterial concentrations suggested that the kidney might be an important site for the elimination of these compounds from plasma and prompted further investigation of the renal handling of these compounds. Tracer doses of either [(3)H]cAMP or [(3)H]cGMP were administered to anesthetized dogs by constant intravenous infusion, and metabolic clearance rates were determined. Concentrations of endogenous cyclic nucleotide and of cyclic nucleotide radioactivity were measured in aortic and renal venous plasma as well as in urine. Renal venous plasma [(3)H]cGMP was 39% and [(3)H]cAMP was 65% of the concentration in arterial plasma. Endogenous cyclic nucleotide levels showed a similar relationship. The plasma clearance rates (PCR) were 271+/-27 ml/min (mean+/-SE) for cGMP and 261+/-17 for cAMP. The total kidney clearance (calculated as the renal plasma flow x renal cyclic nucleotide extraction ratio) accounted for 52+/-4% and 30+/-2% of the PCR for cGMP and cAMP, respectively. Only about two-thirds of the total kidney clearance of each cyclic nucleotide could be accounted for by urinary excretion, the remainder presumably being the result of renal metabolism. The urinary clearances of (3)H-labeled cGMP (40.9+/-4.2 ml/min) and endogenous cGMP (45.0+/-2.3 ml/min) were not significantly different from each other. Both were approximately 50% greater than the glomerular filtration rate, which was 27.1+/-2.0 ml/min, indicating that a significant amount of urinary cGMP is derived from plasma by tubular secretion. In contrast, the urinary clearances of (3)H-labeled cAMP (23.7+/-1.9 ml/min) and endogenous cAMP (27.2+/-2.6 ml/min) were nearly equal both to each other and to the glomerular filtration rate, which was 24.6+/-1.7 ml/min. Thus, in the dog, glomerular filtration of plasma cAMP appears to be responsible for most of the cAMP found in urine. Renla production of cAMP, which in humans contributes from a third to a half of the urinary cAMP, was quantitatively of minor importance in the dog.Thus, under the conditions of these experiments in dogs, renal elimination appears to be responsible for half of the PCR of cGMP and about a third of the PCR of cAMP. About a third of the renal elimination of both cyclic nucleotides appears to be due to metabolic degradation within the kidney, and the balance is due to excretion in the urine.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4357610      PMCID: PMC301450          DOI: 10.1172/JCI107534

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO.

Authors:  J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1963-12       Impact factor: 5.958

2.  Cyclic nucleotide-dependent protein kinases. X. An assay method for the measurement of quanosine 3',5'-monophosphate in various biological materials and a study of agents regulating its levels in heart and brain.

Authors:  J F Kuo; T P Lee; P L Reyes; K G Walton; T E Donnelly; P Greengard
Journal:  J Biol Chem       Date:  1972-01-10       Impact factor: 5.157

3.  Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids.

Authors:  A L Steiner; A S Pagliara; L R Chase; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

4.  Parathyroid function and the renal excretion of 3'5'-adenylic acid.

Authors:  L R Chase; G D Aurbach
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

5.  Measurement of guanosine 3',5'-monophosphate and other cyclic nucleotides. Variations in urinary excretion with hormonal state of the rat.

Authors:  J G Hardman; J W Davis; E W Sutherland
Journal:  J Biol Chem       Date:  1966-10-25       Impact factor: 5.157

6.  Organophosphates of urine, including adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.

Authors:  T D Price; D F Ashman; M M Melicow
Journal:  Biochim Biophys Acta       Date:  1967-05-30

Review 7.  Cyclic nucleotides.

Authors:  J G Hardman; G A Robison; E W Sutherland
Journal:  Annu Rev Physiol       Date:  1971       Impact factor: 19.318

8.  Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.

Authors:  A E Broadus; N I Kaminsky; J G Hardman; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

9.  Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine.

Authors:  A E Broadus; N I Kaminsky; R C Northcutt; J G Hardman; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.

Authors:  N I Kaminsky; A E Broadus; J G Hardman; D J Jones; J H Ball; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

View more
  15 in total

Review 1.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

2.  Hepatic clearance of adenosine 3:5-cyclic monophosphate from plasma in the rat.

Authors:  R C Strange; I W Robb
Journal:  Biochem J       Date:  1975-02       Impact factor: 3.857

3.  Studies of the elevated extracellular concentration of cyclic AMP in uremic man.

Authors:  P Hamet; D A Stouder; H E Ginn; J G Hardman; G W Liddle
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

4.  Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.

Authors:  A Francavilla; A F Jones; T E Starzl
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

5.  Circulating cyclic nucleotides and amines in human cholera.

Authors:  T Morishita; H Asakura; T Hibi; M Tsuchiya; C Uylangco; L Santiago
Journal:  Gastroenterol Jpn       Date:  1981

6.  In vivo evidence that cGMP is the second messenger for atrial natriuretic factor.

Authors:  C L Huang; H E Ives; M G Cogan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  Immunohistochemical localization of 3':5'-cyclic AMP and 3':5'-cyclic GMP in rat renal cortex: effect of parathyroid hormone.

Authors:  T P Dousa; L D Barnes; S H Ong; A L Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

8.  Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension.

Authors:  O Kuchel; F H Messerli; G Tolis; P Hamet; J Fraysse; P Cartier; P Roy; R Boucher; J Genest
Journal:  Can Med Assoc J       Date:  1977-05-07       Impact factor: 8.262

9.  Contraluminal p-aminohippurate transport in the proximal tubule of the rat kidney. VII. Specificity: cyclic nucleotides, eicosanoids.

Authors:  K J Ullrich; G Rumrich; F Papavassiliou; S Klöss; G Fritzsch
Journal:  Pflugers Arch       Date:  1991-05       Impact factor: 3.657

10.  Sources of cyclic nucleotides in plasma.

Authors:  R E Wehmann; L Blonde; A L Steiner
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.